NASDAQ · LRMR

Larimar Therapeutics, Inc.

Last insider buy price $2.67 Paid by Director Thomas Hamilton on Nov 12 (Form 4). Not today's price.

Smart money pulse

What insiders and funds are doing

Buying Insiders: as of Nov 12 Funds: as of Jun 30, 2026
−1000+100 +59
  • group
    7 insiders bought in the last 30 days. $382K in open-market buys, Nov 11–12.
  • account_balance
    101 funds bought, 69 sold in the quarter ended Jun 30, 2026. 35 were new holders.
  • info
    No real insider sales in 12 months. Planned 10b5-1 sales and tax withholding are left out.

−100 means everyone selling, +100 everyone buying. This is data, not advice.

How the Pulse works

Pulse runs from −100 (everyone selling) to +100 (everyone buying). Half comes from insiders: real buyers vs. real sellers in the last 90 days (Form 4). Half comes from funds: funds that bought vs. funds that sold last quarter (13F). 13F is a snapshot of long positions on the last day of the quarter, filed up to 45 days later. It does not show short positions or trades since then.

Who owns it

164 funds report owning LRMR, up from 161

Holdings as of Jun 30, 2026
New35
Added66
Held26
Trimmed37
Sold out32

Last quarter

Who bought and who sold

Change in shares held, biggest holdings first. Bars stop at ±100%.

Insider trades · last 12 months

Real buys and sales

● Open-market buy● Open-market sale
CEOCFOOther officersDirectorsDecJanFebMarAprMayJunJulAugSepOctNovOpen-market buy · Nov 11 · $50KOpen-market buy · Nov 11 · $50KOpen-market buy · Nov 11 · $63.5KOpen-market buy · Nov 11 · $31.6KOpen-market buy · Nov 12 · $187K
CEOCFOOther officersDirectorsJunJulAugSepOctNovOpen-market buy · Nov 11 · $50KOpen-market buy · Nov 11 · $50KOpen-market buy · Nov 11 · $63.5KOpen-market buy · Nov 11 · $31.6KOpen-market buy · Nov 12 · $187K

Last 6 months. A wider screen shows 12.

Showing 7 real trades. Bigger dot means a bigger trade.

Real trades, newest first

Nov 12 Thomas Hamilton Director Open-market buy $187K 70,000 sh at $2.67
Nov 11 Michael Celano CFO Open-market buy $50K 18,460 sh at $2.71
Nov 11 Carole Ben-maimon President and CEO, Director Open-market buy $50K 18,050 sh at $2.77
Nov 11 John Harlow President and COO Open-market buy $49.9K 17,800 sh at $2.80
Nov 11 Frank Thomas Director Open-market buy $21.8K 8,000 sh at $2.73
Nov 11 Gopi Shankar Chief Development Officer Open-market buy $13.5K 5,000 sh at $2.71
Nov 11 Joseph Truitt Director Open-market buy $9.79K 3,500 sh at $2.80

Showing every filing. Dashed circles are routine: grants, tax withholding, option exercises and planned sales.

Top holders

Biggest funds in LRMR

As of Jun 30, 2026

Where this data comes from. Insider trades, fund holdings, activist stakes and company results come from public SEC EDGAR filings (Forms 4, 13F, 13D/13G, 10-Q and 8-K). Congress trades come from the STOCK Act reports members file with the House Clerk and the Senate.

This is data, not investment advice. About StockToast